Sector News

Chemtrade to buy Canexus for $675 million

December 19, 2016
Chemical Value Chain

Chemtrade Logistics Income Fund (Toronto, Ontario, Canada) and Canexus (Calgary, Alberta, Canada) have reached an agreement, under which Chemtrade will acquire Canexus for C$1.65/share in cash.

The transaction is to be completed by way of a plan of arrangement under Alberta’s Business Corporations Act. The deal values Canexus at about C$900 million (US$675 million). The companies confirmed earlier this week that they were discussing a deal at C$1.65/share.

The acquisition price is a 33% premium to Canexus’s closing price of C$1.24/share on 13 September, the last trading day before Chemtrade announced its initial C$1.45/share bid for Canexus. That bid was rejected and Chemtrade launched a hostile C$1.50/share bid for Canexus in October. Chemtrade expects the deal to close by the end of April 2017, subject to regulatory approvals and customary closing conditions.

Shareholders accounting for about 20% of Canexus’s equity, including all Canexus directors and officers, and the company’s largest shareholder Stirling Global Value Fund, have entered into binding agreements to vote their shares in favor of the agreeement, Chemtrade says. Canexus’s shareholders will consider the agreement at a meeting to be held in early February 2017. The deal will require approval from at least 66.67% of shareholders at that meeting.

Chemtrade says it has sufficient capital to fund the acquisition from available cash resources and from firm, committed financing. The company is entitled to a termination fee of C$25 million if Canexus agrees to a “superior proposal” from another company, Chemtrade says. Chemtrade also has the right to match any unsolicited, superior proposal.

Canexus produces sodium chlorate and chlor-alkali products mainly for the pulp and paper, and water tratment industries. The company has production at four plants in Canada and two in Brazil. Chemtrade is a maker of inorganic chemicals, including sulfuric acid, coagulants for water treatment, and sodium chlorate. The proposed deal “will strengthen and expand Chemtrade’s existing platform while further diversifying our North American operations and allowing us to enter attractive South American markets,” says Chemtrade CEO Mark Davis.

Canexus says its board has “unanimously determined that the arrangement is in the best interests of Canexus.” CIBC Capital Markets and The Valence Group are advising Canexus.

By Ian Young

Source: Chemical Week

comments closed

Related News

May 21, 2022

Sika opens new manufacturing plant in Bolivia 

Chemical Value Chain

Sika AG (Baar, Switzerland) has opened a new plant in Santa Cruz de la Sierra, thus doubling its production capacity for mortar and concrete admixtures in Bolivia. With this new facility in one of the country’s main industrial agglomerations, Sika is positioning itself for continued growth in the dynamic Bolivian construction market.

May 21, 2022

Chevron increases renewable fuel market share with REG acquisition

Chemical Value Chain

Chevron Corporation (NYSE: CVX) and Renewable Energy Group, Inc. (NASDAQ: REGI) (REG) announced on Monday a definitive agreement under which Chevron will acquire the outstanding shares of REG in an all-cash transaction valued at $3.15 billion, or $61.50 per share.

May 21, 2022

Lotte Chemical to invest $8 bn on hydrogen energy, battery materials by 2030

Chemical Value Chain

Lotte Chemical Corp. will invest 10 trillion won ($8 billion) on hydrogen and battery materials through 2030 to achieve annual revenue of 50 trillion won and carbon neutrality. The Korean chemical producer on Thursday unveiled its new corporate vision outlining key corporate strategies with focus on growth through hydrogen energy and battery materials businesses.